Rosetta Biosoftware Introduces the Rosetta Resolver Gene Expression Data Analysis System Version 6.0
Rosetta Biosoftware today introduced the Rosetta Resolver(R) gene expression data analysis system 6.0, with capabilities to support toxicogenomics research. The new version of the Resolver system will be presented at the Society of Toxicology annual meeting and ToxExpo in San Diego, California, March 5 to 9, 2006. The new Resolver system 6.0 provides a comprehensive data management and analysis platform for gene expression that can scale to fit the needs of any organization.
“The Resolver system version 6.0 is designed to aid researchers in pinpointing toxicity in lead compounds and uncovering molecular mechanisms of treatments and toxicants,” said Yelena Shevelenko, vice president and general manager of Rosetta Biosoftware. “The latest version of the Resolver system was developed through close work with our customers involved in drug development. Our solution provides customers with unique data mining techniques to minimize costly and time-intensive downstream analysis.”
The Resolver system’s advanced analysis and data management solution enables users to observe expression signatures of toxicity, determine dose effects across multiple treatments, and compare toxicity from one animal model to another. The interoperability of the Resolver system with third-party databases and content-providing applications, such as GeneGo MetaCore(TM), Iconix DrugMatrix(TM), and Ingenuity Pathways Analysis, give researchers the ability to uncover molecular mechanisms of action or determine pathways most impacted by treatments. The application serves as a comprehensive solution for ensuring best practices, regulatory compliance, and collaboration for cross-organization analysis of gene expression data. Further information about the system will be presented at the upcoming Rosetta Technology Forum in Boston on March 9 and 10. To register for this conference, visit www.rosettabio.com/conferences .
The Rosetta Resolver system is developed and supported by Rosetta Biosoftware, and is distributed exclusively by Agilent Technologies.
About Rosetta Biosoftware
Rosetta Biosoftware is a leading provider of informatics solutions for life science research. Its enterprise software solutions, including the Rosetta Resolver and Elucidator systems, empower life scientists with advanced, scalable, and easy-to-use analysis platforms that accelerate discovery research. Rosetta Biosoftware is a business unit of Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co., Inc. (NYSE:MRK). More information about Rosetta Biosoftware is available at www.rosettabio.com .
Rosetta Resolver and Rosetta Elucidator are U.S. registered trademarks of Rosetta Inpharmatics LLC.
